Study S001866

Efficacy and Safety of GLP-1 Agonist Therapy in Overweight and Obese Subjects With Cystic Fibrosis-related Diabetes: a Pilot Study

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)Informed Consent Form (PDF)

Registration

Registration: NCT05788965
Study type: INTERVENTIONAL
Phase: PHASE2; PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 8
Start: 2023-10-16
Primary completion: 2024-12-23
Lead sponsor: University of Minnesota
Conditions: Cystic Fibrosis; Cystic Fibrosis-related Diabetes
Interventions: DRUG:Semaglutide
Results posted: TRUE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Weight [12 weeks]
BMI (kg/m2) [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.